Abstract
Results of Off-Label Venetoclax Use in Combination with Low-Intensity Chemotherapy in Patients with Relapsed and Refractory Myeloid Malignancies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have